The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Humoral Innate Immunity and Acute-Phase Proteins
Open accessAbstract
he broad term "inflammation" encompasses a diverse set of tissue reactions classically triggered by microbial recognition and by tissue damage.1,2 More recently, it has been recognized that dysmetabolic conditions, ranging from diabetes to obesity, elicit overt or subclinical inflammatory reactions.The general role of inflammatory reactions is in the amplification of innate resistance and tissue repair, leading to a return to homeostasis (Fig. 1A).Systemic manifestations of inflammation include fever, alterations in leukocyte counts, cardiovascular reactions, endocrine responses, and reorientation of metabolism in association with increased production of a diverse set of molecules referred to as acute-phase proteins.4,5 The prototypic acute-phase protein, C-reactive protein, was originally described as a molecule that was present in the circulation of patients with infections and that was capable of recognizing the C-type polysaccharides of Streptococcus pneumoniae.6,7 The appearance of increased levels of acutephase proteins in blood and other body fluids (Fig. 1B) is part of a more complex response to local inflammation or to systemic inflammation (e.g., sepsis) that has been referred to as the acute-phase response, 5 which is characterized by decreased production of albumin by hepatocytes, reorientation of iron metabolism, and hormonal changes.4,5 These alterations are also observed in the context of chronic inflammatory conditions and subclinical inflammation.Almost a century after the discovery of C-reactive protein, acute-phase proteins continue to serve as fundamental diagnostic tools that have applications in patients with a range of conditions, including infection, cardiovascular illness, cancer, neurodegeneration, and dysmetabolism.[8][9][10] During the coronavirus disease 2019 (Covid-19) pandemic, acute-phase proteins such as C-reactive protein, fibrinogen and its degradation product d-dimer, and ferritin have served as invaluable tools in the day-to-day management of illnesses and as prognostic indicators (Table 1).Progress has been made in dissecting the production, structure, and function of many of these molecules, and the findings have indicated that a fundamental function of the acute-phase response is to amplify antimicrobial resistance and tissue repair, with many of the acute-phase proteins serving as key components of humoral innate immunity ("ante-antibodies"). 25 From this general perspective, we review key aspects of the production, structure, and function of selected acute-phase proteins, which continue to represent pillar diagnostic tools that could be integrated more systematically into the molecular signatures that have recently emerged from transcriptomic and proteomic profiles. The Conte x t: Cellul a r a nd Humor a l Innate Immunit yInnate immunity is a first line of resistance against microbial pathogens and is involved in the activation of adaptive immune responses, as well as in tissue repair.Innate immunity is made up of a cellular arm and a humoral arm.The molecular strategies used by the cellular arm to sense microbial moieties and tissue damage
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915
Self-citationThe immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182
Serological reactions in pneumonia with a non-protein somatic fraction of Pneumococcus
Tillett, W. S., & Francis, T. (1930) · Journal of Experimental Medicine · doi:10.1084/jem.52.4.561 · Cited by 1,482
Multiple early factors anticipate post-acute COVID-19 sequelae
Su, Y., Yuan, D., Chen, D. G., Ng, R. H., Wang, K., Choi, J., Li, S., Hong, S., Zhang, R., Xie, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.014 · Cited by 1,156
Interleukin-1 and the Pathogenesis of the Acute-Phase Response
Epstein, F. H., & Dinarello, C. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411293112205 · Cited by 1,146
Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
Mantovani, A., Dinarello, C. A., Molgora, M., & Garlanda, C. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.012 · Cited by 1,046
Self-citationPhetsouphanh, C., Darley, D. R., Wilson, D. B., Howe, A., Munier, C. M. L., Patel, S. K., Juno, J. A., Burrell, L. M., Kent, S. J., Dore, G. J., et al. (2022) · Nature Immunology · doi:10.1038/s41590-021-01113-x · Cited by 1,015
Distinguishing features of long COVID identified through immune profiling
Klein, J., Wood, J., Jaycox, J. R., Dhodapkar, R. M., Lu, P., Gehlhausen, J. R., Tabachnikova, A., Greene, K., Tabacof, L., Malik, A. A., et al. (2023) · Nature · doi:10.1038/s41586-023-06651-y · Cited by 806
Collectins and Ficolins: Humoral Lectins of the Innate Immune Defense
Holmskov, U., Thiel, S., & Jensenius, J. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.140954 · Cited by 762
The immunology and immunopathology of COVID-19
Merad, M., Blish, C. A., Sallusto, F., & Iwasaki, A. (2022) · Science · doi:10.1126/science.abm8108 · Cited by 751
The spectrum of inflammatory responses
Medzhitov, R. (2021) · Science · doi:10.1126/science.abi5200 · Cited by 718
Grasselli, G., Tonetti, T., Protti, A., Langer, T., Girardis, M., Bellani, G., Laffey, J., Carrafiello, G., Carsana, L., Rizzuto, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30370-2 · Cited by 694
Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response
Garlanda, C., Hirsch, E., Bozza, S., Salustri, A., De Acetis, M., Nota, R., Maccagno, A., Riva, F., Bottazzi, B., Peri, G., et al. (2002) · Nature · doi:10.1038/nature01195 · Cited by 669
Self-citationC Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC) (2011) · BMJ · doi:10.1136/bmj.d548 · Cited by 642
Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis
Tian, W., Jiang, W., Yao, J., Nicholson, C. J., Li, R. H., Sigurslid, H. H., Wooster, L., Rotter, J. I., Guo, X., & Malhotra, R. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26050 · Cited by 640
Unexplained post-acute infection syndromes
Choutka, J., Jansari, V., Hornig, M., & Iwasaki, A. (2022) · Nature Medicine · doi:10.1038/s41591-022-01810-6 · Cited by 604
An Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm
Bottazzi, B., Doni, A., Garlanda, C., & Mantovani, A. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101305 · Cited by 592
Self-citationSano, T., Huang, W., Hall, J. A., Yang, Y., Chen, A., Gavzy, S. J., Lee, J.-Y., Ziel, J. W., Miraldi, E. R., Domingos, A. I., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.061 · Cited by 547
Jaillon, S., Peri, G., Delneste, Y., Frémaux, I., Doni, A., Moalli, F., Garlanda, C., Romani, L., Gascan, H., Bellocchio, S., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061301 · Cited by 534
Self-citationPretorius, E., Vlok, M., Venter, C., Bezuidenhout, J. A., Laubscher, G. J., Steenkamp, J., & Kell, D. B. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01359-7 · Cited by 518
Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity
Bickerstaff, M. C. M., Botto, M., Hutchinson, W. L., Herbert, J., Tennent, G. A., Bybee, A., Mitchell, D. A., Cook, H. T., Butler, P. J. G., Walport, M. J., et al. (1999) · Nature Medicine · doi:10.1038/9544 · Cited by 489
Novel mechanisms and functions of complement
Hajishengallis, G., Reis, E. S., Mastellos, D. C., Ricklin, D., & Lambris, J. D. (2017) · Nature Immunology · doi:10.1038/ni.3858 · Cited by 488
Complement as a target in COVID-19?
Risitano, A. M., Mastellos, D. C., Huber-Lang, M., Yancopoulou, D., Garlanda, C., Ciceri, F., & Lambris, J. D. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0320-7 · Cited by 484
Self-citationAcute Respiratory Tract Infections and Mannose-Binding Lectin Insufficiency During Early Childhood
Koch, A. (2001) · JAMA · doi:10.1001/jama.285.10.1316 · Cited by 425
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
Bodin, K., Ellmerich, S., Kahan, M. C., Tennent, G. A., Loesch, A., Gilbertson, J. A., Hutchinson, W. L., Mangione, P. P., Gallimore, J. R., Millar, D. J., et al. (2010) · Nature · doi:10.1038/nature09494 · Cited by 341
Muller, B., Peri, G., Doni, A., Torri, V., Landmann, R., Bottazzi, B., & Mantovani, A. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00017 · Cited by 329
Self-citationA guide to immunotherapy for COVID-19
van de Veerdonk, F. L., Giamarellos-Bourboulis, E., Pickkers, P., Derde, L., Leavis, H., van Crevel, R., Engel, J. J., Wiersinga, W. J., Vlaar, A. P. J., Shankar-Hari, M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01643-9 · Cited by 320
Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.
Gabay, C., Smith, M. F., Eidlen, D., & Arend, W. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119488 · Cited by 319
Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype.
Cairo, G., Recalcati, S., Mantovani, A., & Locati, M. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.03.007 · Cited by 312
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation
Cunha, C., Aversa, F., Lacerda, J. F., Busca, A., Kurzai, O., Grube, M., Löffler, J., Maertens, J. A., Bell, A. S., Inforzato, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1211161 · Cited by 307
Self-citationStructural recognition and functional activation of FcγR by innate pentraxins
Lu, J., Marnell, L. L., Marjon, K. D., Mold, C., Du Clos, T. W., & Sun, P. D. (2008) · Nature · doi:10.1038/nature07468 · Cited by 301
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
Lempp, F. A., Soriaga, L. B., Montiel-Ruiz, M., Benigni, F., Noack, J., Park, Y.-J., Bianchi, S., Walls, A. C., Bowen, J. E., Zhou, J., et al. (2021) · Nature · doi:10.1038/s41586-021-03925-1 · Cited by 297
THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD
Abernethy, T. J., & Avery, O. T. (1941) · Journal of Experimental Medicine · doi:10.1084/jem.73.2.173 · Cited by 286
(1979) · PubMed Central · Cited by 271
AA Amyloidosis: Pathogenesis and Targeted Therapy
Westermark, G. T., Fändrich, M., & Westermark, P. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163913 · Cited by 264
Hyperglycemia-induced Production of Acute Phase Reactants in Adipose Tissue
Lin, Y., Rajala, M. W., Berger, J. P., Moller, D. E., Barzilai, N., & Scherer, P. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107101200 · Cited by 254
Buck, M., Gouwy, M., Wang, J., Snick, J., Opdenakker, G., Struyf, S., & Damme, J. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160418114600 · Cited by 248
Serum amyloid A is an innate immune opsonin for Gram-negative bacteria
Shah, C., Hari-Dass, R., & Raynes, J. G. (2006) · Blood · doi:10.1182/blood-2005-11-011932 · Cited by 245
Bellmann-Weiler, R., Lanser, L., Barket, R., Rangger, L., Schapfl, A., Schaber, M., Fritsche, G., Wöll, E., & Weiss, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082429 · Cited by 244
PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer
Garlanda, C., Bottazzi, B., Magrini, E., Inforzato, A., & Mantovani, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00016.2017 · Cited by 210
Self-citationGritti, G., Raimondi, F., Bottazzi, B., Ripamonti, D., Riva, I., Landi, F., Alborghetti, L., Frigeni, M., Damiani, M., Micò, C., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01299-x · Cited by 210
Self-citationCecconi, M., Piovani, D., Brunetta, E., Aghemo, A., Greco, M., Ciccarelli, M., Angelini, C., Voza, A., Omodei, P., Vespa, E., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051548 · Cited by 189
Association of elevated inflammatory markers and severe COVID-19: A meta-analysis
Ji, P., Zhu, J., Zhong, Z., Li, H., Pang, J., Li, B., & Zhang, J. (2020) · Medicine · doi:10.1097/md.0000000000023315 · Cited by 181
Danwang, C., Endomba, F. T., Nkeck, J. R., Wouna, D. L. A., Robert, A., & Noubiap, J. J. (2020) · Biomarker Research · doi:10.1186/s40364-020-00217-0 · Cited by 167
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19
Brunetta, E., Folci, M., Bottazzi, B., Santis, M. D., Gritti, G., Protti, A., Mapelli, S. N., Bonovas, S., Piovani, D., Leone, R., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-00832-x · Cited by 167
Self-citationRecognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules
Stravalaci, M., Pagani, I., Paraboschi, E. M., Pedotti, M., Doni, A., Scavello, F., Mapelli, S. N., Sironi, M., Perucchini, C., Varani, L., et al. (2022) · Nature Immunology · doi:10.1038/s41590-021-01114-w · Cited by 166
Self-citationJenny, N. S., Arnold, A. M., Kuller, L. H., Tracy, R. P., & Psaty, B. M. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.178947 · Cited by 163
Gutmann, C., Takov, K., Burnap, S. A., Singh, B., Ali, H., Theofilatos, K., Reed, E., Hasman, M., Nabeebaccus, A., Fish, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23494-1 · Cited by 161
SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry
Kee, J., Thudium, S., Renner, D. M., Glastad, K. M., Palozola, K. C., Zhang, Z., Li, Y., Lan, Y., Cesare, J., Poleshko, A. S., et al. (2022) · Nature · doi:10.1038/s41586-022-05282-z · Cited by 152
Doni, A., Musso, T., Morone, D., Bastone, A., Zambelli, V., Sironi, M., Castagnoli, C., Cambieri, I., Stravalaci, M., Pasqualini, F., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141268 · Cited by 151
Self-citationLong Covid: where we stand and challenges ahead
Mantovani, A., Morrone, M. C., Patrono, C., Santoro, M., Schiaffino, S., Remuzzi, G., Bussolati, G., On behalf of the Covid-19 Commission of the Accademia Nazionale dei Lincei, Cappuccinelli, P., Fitzgerald, G., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01052-6 · Cited by 141
Self-citationFyfe, A. I., Rothenberg, L. S., deBeer, F. C., Cantor, R. M., Rotter, J. I., & Lusis, A. J. (1997) · Circulation · doi:10.1161/01.cir.96.9.2914 · Cited by 135
Jaillon, S., Moalli, F., Ragnarsdottir, B., Bonavita, E., Puthia, M., Riva, F., Barbati, E., Nebuloni, M., Cvetko Krajinovic, L., Markotic, A., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.015 · Cited by 132
Self-citationPTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant: Figure 1.
Wójtowicz, A., Lecompte, T., Bibert, S., Manuel, O., Rüeger, S., Berger, C., Boggian, K., Cusini, A., Garzoni, C., Hirsch, H. H., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ386 · Cited by 116
Acute-phase protein synthesis: a key feature of innate immune functions of the liver
Ehlting, C., Wolf, S. D., & Bode, J. G. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0209 · Cited by 115
Nonresolving inflammation redux
Nathan, C. (2022) · Immunity · doi:10.1016/j.immuni.2022.03.016 · Cited by 115
Garred, P., Pressler, T., Lanng, S., MADSEN, H. O., Moser, C. E., Laursen, I., Balstrup, F., Koch, C., & Koch, C. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10064 · Cited by 114
Connolly, M., Marrelli, A., Blades, M. C., McCormick, J., MADERNA, P., Godson, C., Mullan, R. H., FitzGerald, O., Bresnihan, B., Pitzalis, C., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902941 · Cited by 105
Raghu, G., van den Blink, B., Hamblin, M. J., Brown, A. W., Golden, J. A., Ho, L. A., Wijsenbeek, M. S., Vašáková, M., Pesci, A., Antin-Ozerkis, D. E., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30172-9 · Cited by 103
Inflammation-Induced Acute Phase Response in Skeletal Muscle and Critical Illness Myopathy
Langhans, C., Weber-Carstens, S., Schmidt, F., Hamati, J., Kny, M., Zhu, X., Wollersheim, T., Koch, S., Krebs, M., Schulz, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092048 · Cited by 101
Mannose Binding Lectin Acute Phase Activity in Patients with Severe Infection
Dean, M. M., Minchinton, R. M., Heatley, S. L., & Eisen, D. P. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-4702-1 · Cited by 99
Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial
Caironi, P., Masson, S., Mauri, T., Bottazzi, B., Leone, R., Magnoli, M., Barlera, S., Mamprin, F., Fedele, A., Mantovani, A., et al. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12704 · Cited by 87
Self-citationIL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination
Thurner, L., Kessel, C., Fadle, N., Regitz, E., Seidel, F., Kindermann, I., Lohse, S., Kos, I., Tschöpe, C., Kheiroddin, P., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2205667 · Cited by 83
Intracellular complement activation—An alarm raising mechanism?
Reichhardt, M. P., & Meri, S. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.03.003 · Cited by 76
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
Captur, G., Moon, J., Topriceanu, C., Joy, G., Swadling, L., Hällqvist, J., Doykov, I., Patel, N., Śpiewak, J., Baldwin, T., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104293 · Cited by 76
Serum amyloid P component is an essential element of resistance against Aspergillus fumigatus
Doni, A., Parente, R., Laface, I., Magrini, E. I., Cunha, C., Colombo, F., de Lacerda, J. F., Campos, A., Mapelli, S. N., Petroni, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24021-y · Cited by 74
Self-citationThe Pentraxins 1975–2018: Serendipity, Diagnostics and Drugs
Pepys, M. B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02382 · Cited by 67
Zinellu, A., Paliogiannis, P., Carru, C., & Mangoni, A. A. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.03.025 · Cited by 61
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101
Skendros, P., Germanidis, G. S., Mastellos, D. C., Antoniadou, C., Gavriilidis, E., Kalopitas, G., Samakidou, A., Liontos, A., Chrysanthopoulou, A., Ntinopoulou, M., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo2341 · Cited by 58
Molecular Biology of the Acute Phase Plasma Proteins
Gitlin, J. D., & Colten, H. R. (1987) · Elsevier eBooks · doi:10.1016/b978-0-12-432014-7.50009-7 · Cited by 42
Prediction of Respiratory Failure and Mortality in COVID-19 Patients Using Long Pentraxin PTX3
Hansen, C. B., Sandholdt, H., Møller, M. E. E., Pérez‐Alós, L., Pedersen, L., Israelsen, S. B., Garred, P., & Benfield, T. (2022) · Journal of Innate Immunity · doi:10.1159/000521612 · Cited by 29
Gonçales, R. A., Bastos, H. N., Duarte‐Oliveira, C., Antunes, D., Sokhatska, O., Jacob, M., Rolo, R., Campos, C. F., Sasaki, S. D., Donato, A., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202112-2771oc · Cited by 26
Self-citationLapadula, G., Leone, R., Bernasconi, D. P., Biondi, A., Rossi, E., D’Angiò, M., Bottazzi, B., Bettini, L. R., Beretta, I., Garlanda, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.933960 · Cited by 24
Self-citationBai, X., Bai, A., Tomasicchio, M., Hagman, J. R., Buckle, A. M., Gupta, A. A., Kadiyala, V., Bevers, S. G., Serban, K. A., Kim, K., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200227 · Cited by 20
Protective α1-antitrypsin effects in autoimmune vasculitis are compromised by methionine oxidation
Ebert, M., Jerke, U., Eulenberg-Gustavus, C., Kling, L., Jenne, D. E., Kirchner, M., Mertins, P., Bieringer, M., Elitok, S., Eckardt, K., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci160089 · Cited by 20
Cited by
Persistent complement dysregulation with signs of thromboinflammation in active Long Covid
Cervia-Hasler, C., Brüningk, S. C., Hoch, T., Fan, B., Muzio, G., Thompson, R. C., Ceglarek, L., Meledin, R., Westermann, P., Emmenegger, M., et al. (2024) · Science · doi:10.1126/science.adg7942 · Cited by 408
Liu, H., Yin, G., Franco Leonardi, B., Lan, T., Ait Ahmed, Y., Berger, H., Kohlhepp, M. S., Amiridze, N., Martagón Calderón, N., Frau, C., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-334425 · Cited by 23
Chang, T.-M., Wu, C.-C., Huang, H.-C., Wang, S.-S., Chuang, C.-H., Kao, P.-L., Tang, W.-H., Liu, L. T.-C., Qiu, W.-Y., Percec, I., et al. (2024) · doi:10.1101/2024.12.03.624435 · Cited by 7
Metadata
- Authors
- Mantovani, A., & Garlanda, C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-02-02
- Volume
- 388
- Issue
- 5
- Pages
- 439-452
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4318931822
- Cited by
- 310
- References
- 77
- FWCI
- 27.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.